Cargando…

BDNF methylation and mRNA expression in brain and blood of completed suicides in Slovenia

BACKGROUND: Suicide is a major public health problem. Worldwide, around 800000 people die by suicide every year. Suicide is a multifactorial disorder, with numerous environmental and genetic risk factors involved. Among the candidate genes, changes in the BDNF locus at the gene, epigenetic, mRNA, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ropret, Sandra, Kouter, Katarina, Zupanc, Tomaž, Videtic Paska, Alja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717036/
https://www.ncbi.nlm.nih.gov/pubmed/35070779
http://dx.doi.org/10.5498/wjp.v11.i12.1301
_version_ 1784624450440790016
author Ropret, Sandra
Kouter, Katarina
Zupanc, Tomaž
Videtic Paska, Alja
author_facet Ropret, Sandra
Kouter, Katarina
Zupanc, Tomaž
Videtic Paska, Alja
author_sort Ropret, Sandra
collection PubMed
description BACKGROUND: Suicide is a major public health problem. Worldwide, around 800000 people die by suicide every year. Suicide is a multifactorial disorder, with numerous environmental and genetic risk factors involved. Among the candidate genes, changes in the BDNF locus at the gene, epigenetic, mRNA, and protein expression levels have been implicated in psychiatric disorders, including suicidal behavior and completed suicides. AIM: To investigate changes in BDNF methylation and expression of four alternative BDNF transcripts for association with completed suicide. METHODS: This case-control study included 42 unrelated male Caucasian subjects, where 20 were control subjects who died following acute cardiac arrest, and 22 were suicide victims who died by hanging. DNA and RNA were extracted from brain tissue (Brodmann area 9 and hippocampus) and from blood. DNA methylation and mRNA expression levels were determined by targeted bisulfite next-generation sequencing and reverse-transcription quantitative PCR. Statistical analysis was done by use of two-tailed Student’s t tests for two independent samples, and the Benjamini-Hochberg procedure was implemented for correction for multiple comparisons. RESULTS: In DNA from brain tissue, there were no significant differences in BDNF methylation between the study groups. However, data showed significantly reduced DNA methylation of the BDNF region upstream of exon I in blood samples of suicide victims compared to the controls (5.67 ± 0.57 vs 6.83 ± 0.64, P(corr) = 0.01). In Brodmann area 9 of the brain of the suicide victims but not in their hippocampus, there was higher expression of BDNF transcript I-IX (NM_170731.4) compared to the controls (0.077 ± 0.024 vs 0.05 ± 0.013, P = 0.042). In blood, expression analysis for the BDNF transcripts was not feasible due to extensive RNA degradation. CONCLUSION: Despite the limitations of the study, the obtained data further support a role for BDNF in suicidality. However, it should be noted that suicidal behavior is a multifactorial disorder with numerous environmental and genetic risk factors involved.
format Online
Article
Text
id pubmed-8717036
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-87170362022-01-20 BDNF methylation and mRNA expression in brain and blood of completed suicides in Slovenia Ropret, Sandra Kouter, Katarina Zupanc, Tomaž Videtic Paska, Alja World J Psychiatry Case Control Study BACKGROUND: Suicide is a major public health problem. Worldwide, around 800000 people die by suicide every year. Suicide is a multifactorial disorder, with numerous environmental and genetic risk factors involved. Among the candidate genes, changes in the BDNF locus at the gene, epigenetic, mRNA, and protein expression levels have been implicated in psychiatric disorders, including suicidal behavior and completed suicides. AIM: To investigate changes in BDNF methylation and expression of four alternative BDNF transcripts for association with completed suicide. METHODS: This case-control study included 42 unrelated male Caucasian subjects, where 20 were control subjects who died following acute cardiac arrest, and 22 were suicide victims who died by hanging. DNA and RNA were extracted from brain tissue (Brodmann area 9 and hippocampus) and from blood. DNA methylation and mRNA expression levels were determined by targeted bisulfite next-generation sequencing and reverse-transcription quantitative PCR. Statistical analysis was done by use of two-tailed Student’s t tests for two independent samples, and the Benjamini-Hochberg procedure was implemented for correction for multiple comparisons. RESULTS: In DNA from brain tissue, there were no significant differences in BDNF methylation between the study groups. However, data showed significantly reduced DNA methylation of the BDNF region upstream of exon I in blood samples of suicide victims compared to the controls (5.67 ± 0.57 vs 6.83 ± 0.64, P(corr) = 0.01). In Brodmann area 9 of the brain of the suicide victims but not in their hippocampus, there was higher expression of BDNF transcript I-IX (NM_170731.4) compared to the controls (0.077 ± 0.024 vs 0.05 ± 0.013, P = 0.042). In blood, expression analysis for the BDNF transcripts was not feasible due to extensive RNA degradation. CONCLUSION: Despite the limitations of the study, the obtained data further support a role for BDNF in suicidality. However, it should be noted that suicidal behavior is a multifactorial disorder with numerous environmental and genetic risk factors involved. Baishideng Publishing Group Inc 2021-12-19 /pmc/articles/PMC8717036/ /pubmed/35070779 http://dx.doi.org/10.5498/wjp.v11.i12.1301 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Case Control Study
Ropret, Sandra
Kouter, Katarina
Zupanc, Tomaž
Videtic Paska, Alja
BDNF methylation and mRNA expression in brain and blood of completed suicides in Slovenia
title BDNF methylation and mRNA expression in brain and blood of completed suicides in Slovenia
title_full BDNF methylation and mRNA expression in brain and blood of completed suicides in Slovenia
title_fullStr BDNF methylation and mRNA expression in brain and blood of completed suicides in Slovenia
title_full_unstemmed BDNF methylation and mRNA expression in brain and blood of completed suicides in Slovenia
title_short BDNF methylation and mRNA expression in brain and blood of completed suicides in Slovenia
title_sort bdnf methylation and mrna expression in brain and blood of completed suicides in slovenia
topic Case Control Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717036/
https://www.ncbi.nlm.nih.gov/pubmed/35070779
http://dx.doi.org/10.5498/wjp.v11.i12.1301
work_keys_str_mv AT ropretsandra bdnfmethylationandmrnaexpressioninbrainandbloodofcompletedsuicidesinslovenia
AT kouterkatarina bdnfmethylationandmrnaexpressioninbrainandbloodofcompletedsuicidesinslovenia
AT zupanctomaz bdnfmethylationandmrnaexpressioninbrainandbloodofcompletedsuicidesinslovenia
AT videticpaskaalja bdnfmethylationandmrnaexpressioninbrainandbloodofcompletedsuicidesinslovenia